Distinct Components of Retrograde CaV1.1-RyR1 Coupling Revealed by a Lethal Mutation in RyR1 by Sheridan, David
Otterbein University 
Digital Commons @ Otterbein 
Biology and Earth Science Faculty Scholarship Biology and Earth Science 
2-23-2016 
Distinct Components of Retrograde CaV1.1-RyR1 Coupling 
Revealed by a Lethal Mutation in RyR1 
David Sheridan 
Otterbein University 
Follow this and additional works at: https://digitalcommons.otterbein.edu/bio_fac 
 Part of the Biology Commons 
Repository Citation 
Sheridan, David, "Distinct Components of Retrograde CaV1.1-RyR1 Coupling Revealed by a Lethal 
Mutation in RyR1" (2016). Biology and Earth Science Faculty Scholarship. 22. 
https://digitalcommons.otterbein.edu/bio_fac/22 
This Article is brought to you for free and open access by the Biology and Earth Science at Digital Commons @ 
Otterbein. It has been accepted for inclusion in Biology and Earth Science Faculty Scholarship by an authorized 
administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Article
Distinct Components of Retrograde CaV1.1-RyR1 Coupling Revealed by a
Lethal Mutation in RyR1
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1Cardiology Division, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado; 2Department of Biology and Earth
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ABSTRACT The molecular basis for excitation-contraction coupling in skeletal muscle is generally thought to involve confor-
mational coupling between the L-type voltage-gated Ca2þ channel (CaV1.1) and the type 1 ryanodine receptor (RyR1). This
coupling is bidirectional; in addition to the orthograde signal from CaV1.1 to RyR1 that triggers Ca
2þ release from the sarco-
plasmic reticulum, retrograde signaling from RyR1 to CaV1.1 results in increased amplitude and slowed activation kinetics of
macroscopic L-type Ca2þ current. Orthograde coupling was previously shown to be ablated by a glycine for glutamate substi-
tution at RyR1 position 4242. In this study, we investigated whether the RyR1-E4242G mutation affects retrograde coupling.
L-type current in myotubes homozygous for RyR1-E4242G was substantially reduced in amplitude (~80%) relative to that
observed in myotubes from normal control (wild-type and/or heterozygous) myotubes. Analysis of intramembrane gating charge
movements and ionic tail current amplitudes indicated that the reduction in current amplitude during step depolarizations was a
consequence of both decreased CaV1.1 membrane expression (~50%) and reduced channel Po (~55%). In contrast, activation
kinetics of the L-type current in RyR1-E4242G myotubes resembled those of normal myotubes, unlike dyspedic (RyR1 null)
myotubes in which the L-type currents have markedly accelerated activation kinetics. Exogenous expression of wild-type
RyR1 partially restored L-type current density. From these observations, we conclude that mutating residue E4242 affects
RyR1 structures critical for retrograde communication with CaV1.1. Moreover, we propose that retrograde coupling has two
distinct and separable components that are dependent on different structural elements of RyR1.
INTRODUCTION
In skeletal muscle, conformational coupling between the
L-type voltage-gated Ca2þ channel (CaV1.1) and the
type 1 ryanodine receptor (RyR1) appears to be respon-
sible for the release of Ca2þ from the sarcoplasmic retic-
ulum in response to depolarization of the plasma
membrane, resulting in the activation of the contractile
filaments (1–4). Twenty years ago, Nakai et al. (5) estab-
lished that in addition to this orthograde signal transmitted
from CaV1.1 to RyR1, there was also a retrograde signal
from RyR1 to CaV1.1. Specifically, examination of
L-type Ca2þ currents in myotubes harvested from dyspedic
(RyR1 null) mice revealed that CaV1.1 channel open prob-
ability (Po) was greatly reduced, implying that the pres-
ence of RyR1 somehow increases CaV1.1 Po (5–8).
Subsequent studies have shown that RyR1 also has a
profound impact on CaV1.1 activation kinetics, as L-type
currents in dyspedic myotubes display accelerated ac-
tivation in comparison to those of normal myotubes
or dyspedic myotubes transfected with wild-type
RyR1 (8–10). In addition, CaV1.1 gating is directly
impacted by ryanodine-induced conformational changes
in RyR1 (11,12).
There has been extensive work to identify regions of
CaV1.1 and its auxiliary b1a subunit, which are important
for bidirectional coupling with RyR1 (13), with the result
that the nonconserved sequences of both that are important
for this signaling have been somewhat well defined
(14–18). Similarly, there have been a number of studies at-
tempting to identify regions of RyR1 important for bidirec-
tional signaling; these have employed both traditional
biochemical methods (19–22), and expression of RyR1/
RyR2 or RyR1/RyR3 chimeras in dyspedic myotubes
(6,10,23–26). These studies have provided some informa-
tion on regions of primary sequence within the myoplasmic
foot domain of RyR1 that affect conformational coupling.
However, these studies were carried out largely in the
absence of information about the three-dimensional
arrangement of the primary sequence, and the regions of
RyR1 found to be important were relatively large. Thus,
much less is known about the structures of RyR1 involved
in coupling to CaV1.1, particularly those involved in retro-
grade coupling.
Recently, a mutant mouse strain carrying a recessively in-
herited defect in RyR1 was generated (27). Pups homozy-
gous for this mutation (RyR1-E4242G) died perinatally
from asphyxiation and displayed gross morphology similar
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to that of the four existing excitation-contraction (EC)
coupling-defective model mouse strains (dysgenic, dyspe-
dic, b1 null, and Stac3 null). Myotubes cultured from these
homozygous mutant mice (hereafter referred to as RyR1-
E4242G) were incapable of supporting depolarization-
induced myoplasmic Ca2þ transients and electrically
evoked contractions; these latter observations made in our
laboratory indicated that mutation ablated orthograde
CaV1.1-RyR1 coupling.
The purpose of this study was to investigate whether
retrograde coupling is also disrupted by the RyR1-
E4242G mutation. Our results indicate that the RyR1-
E4242G mutation markedly reduces L-type current density,
CaV1.1 Po, and CaV1.1 expression, where this last effect is
most likely a consequence of the absence of EC coupling
(see Avila et al. (28)). The effects of the RyR1-E4242G
mutation on current density, relative Po, and channel expres-
sion are similar to those occurring in dyspedic myotubes in
which RyR1 has been genetically ablated (5). However,
L-type currents of myotubes homozygous for RyR1-
E4242G retained the slow activation kinetics characteristic
of normal myotubes. As a result of these observations, we
conclude that the two components that have been described
earlier for retrograde coupling, increased Po and slowed
activation, are in fact separable. Thus, we propose that these
two physiological effects rely on different structural ele-
ments of RyR1.
MATERIALS AND METHODS
Myotube culture
All procedures involving mice were approved by the University of
Colorado Denver-Anschutz Medical Campus Institutional Animal Care
and Use Committee. Primary cultures of phenotypically normal (þ/þ
or þ/RyR1AG), RyR1-E4242G homozygous (RyR1AG/RyR1AG), and dys-
pedic (RyR1/RyR1) myotubes were prepared from E18.5 mice as
described previously in Beam and Franzini-Armstrong (29). Like dyspe-
dic mice, RyR1-E4242G mice died from respiratory failure upon parturi-
tion (27). Myoblasts were plated into 35 mm ECL-coated, plastic culture
dishes (Falcon, Corning, NY). Cultures were grown for 6–7 days in a hu-
midified 37C incubator with 5% CO2 in Dulbecco’s Modified Eagle
Medium (Mediatech, Tewksbury, MA), supplemented with 10% fetal
bovine serum/10% horse serum (Hyclone Laboratories, Logan, UT).
This medium was then replaced with differentiation medium (Dulbecco’s
Modified Eagle Medium supplemented with 2% horse serum). For elec-
trophysiological experiments, myotubes were examined 4–6 days postdif-
ferentiation. In some cases, single nuclei of RyR1-E4242G myotubes
were microinjected with a solution of plasmid cDNA encoding an
RyR1-YFP fusion construct (500 ng/mL; see below) two days postdiffer-
entiation and four days before experiments. Data were obtained from
4 and 10 independent cultures of normal and RyR1-E4242G homozygous
myotubes, respectively.
Ca2D current recordings
Pipettes were fabricated from borosilicate glass and had resistances of
~2.0 MU when filled with internal solution, which consisted of 140 mM
Cs-aspartate, 10 mM Cs2-EGTA, 5 mM MgCl2, and 10 mM HEPES,
pH 7.4 with CsOH. The external recording solution contained 145 mM
tetraethylammonium-Cl, 10 mM CaCl2, 0.003 mM tetrodotoxin, and
10 mM HEPES, pH 7.4 with tetraethylammonium-OH. Linear capacitative
and leakage currents were determined by averaging the currents elicited by
eleven 30-mV hyperpolarizing pulses from a holding potential of 80 mV.
Test currents were corrected for linear components of leak and capacitive
current by digital scaling and subtraction of this average control current.
Electronic compensation was used to reduce the effective series resistance
(usually to<1 MU) and the time constant for charging the linear cell capac-
itance (usually to <0.5 ms). Ionic currents were filtered at 2–5 kHz
and digitized at 10 kHz. To measure macroscopic L-type current in isola-
tion, a 1 s prepulse to 20 mV followed by a 100 ms repolarization
to 50 mV was administered before the test pulse (prepulse protocol; see
Adams et al. (30)) to inactivate voltage-gated Naþ and T-type Ca2þ chan-
nels. Cell capacitance was determined by integration of a transient
from 80 to 70 mV using Clampex 8.0 (Molecular Devices, Sunnyvale,
CA) and was used to normalize current amplitudes (pA/pF). I/V curves were
fitted using the following equation:
I ¼ Gmax  ðV  VrevÞ

1þ exp V  V1=2

kG

;
(1)
where I is the current for the test potential V, Vrev is the reversal potential,
Gmax is the maximum Ca
2þ channel conductance, V1/2 is the half-maximal
activation potential, and kG is the slope factor. The activation phase of
L-type currents was fitted using the following exponential function:
IðtÞ ¼ Afast

exp
 ttfast
þ Aslow½expð  t=tslowÞ þ C;
(2)
where I(t) is the current at time t after the depolarization, Afast and Aslow are
the steady-state current amplitudes of each component with their respective
time constants of activation (tfast and tslow), and C represents the steady-
state peak current (as in Avila and Dirksen (8)).
Tail current amplitude (Itail) was measured 1 ms after the onset of the
repolarization from the test pulse to50 mV (31) and was used to calculate
conductance via Ohm’s law. In some experiments, L-type currents were
recorded in the continuous presence of racemic Bay K 8644 (5 mM; kindly
supplied by Dr. A. Scriabine, Miles Laboratories, Elkhart, IN) in the bath
solution.
Measurement of charge movements
For measurement of intramembrane charge movements, ionic currents were
blocked by the addition of 0.5 mM CdCl2 þ 0.1 mM LaCl3 to the standard
extracellular recording solution. All charge movements were measured with
the prepulse protocol (see above) and were corrected for linear cell capac-
itance and leakage currents using aP/6 subtraction protocol. Filtering was
at 2–5 kHz (eight-pole Bessel filter; Frequency Devices, Ottawa, IL) and
digitization was at 20 kHz. Voltage-clamp command pulses were exponen-
tially rounded with a time constant of 50–500 ms. The integral of the ON
transient (Qon) for each test potential (V) was fitted according to
Qon ¼ Qmax

1þ exp V  VQ

kQ

; (3)
where Qmax is the maximal Qon, VQ is the potential causing movement of
half the maximal charge, and kQ is a slope parameter. For dyspedic myo-
tubes, the normalized conductance (Itail/Qmax) versus prior test potential
(V) relationship was fitted according to
Itail=Qmax ¼ 1=f1þ exp½  ðV  VtailÞ=ktailg; (4)
where Vtail is the potential causing half-maximal tail current and ktail is a
slope parameter.
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Construction of RyR1-YFP
The plasmid containing RyR1-YFP was created in three steps using YFP-
rabbit RyR1 (GenBank: X68650; a kind gift from Dr. M. Grabner) as a tem-
plate. We first replaced the Acc65I restriction enzyme site at nucleotide
2,235 with a unique EcoRV site via a silent mutation (cgg tac c to cga
tat c). This change was accomplished via a two-step, overlapping sequence
PCR strategy with the primers designed to create a 1650 basepair product
(50 gctagcgctaccggtcgcc 30 and reverse 50 gccagatatcgtccggtgg 30) and a
separate 4084 basepair product (forward 50 ggacgatatctggcactcacc 30 and
reverse 50 ccatgccaccggttctcc 30). These two PCR products were individu-
ally subcloned into separate TOPO PCR 2.1 vectors (Invitrogen, Carlsbad,
CA). Both subcloned products were excised with AgeI and EcoRV and
ligated into an AgeI-digested YFP-RyR1 via a three-piece ligation reaction.
Next, we removed the carboxyl-terminal stop codon and inserted two nucle-
otide bases to this new, to our knowledge, EcoRV-modified YFP-RyR1
construct as a means to prevent the future carboxyl-terminal YFP from
being out of frame. To do so, we used the forward primer 50 ggtatactac
ttcctggagg 30 and the reverse primer 50 gatcctctggtaccgctcagc 30 to create
a 1245-basepair product that was subsequently subcloned into TOPO
PCR 2.1. The subcloned piece was then excised with BstZ17I and
Acc65I and ligated into a similarly cut EcoRV-modified YFP-RyR1
construct. Finally, the entire 15.1 kb modified RyR1 construct with EcoRV
and ablated stop codon was excised with HindIII and Acc65I and ligated
into a similarly cut YFP-N1 vector (Invitrogen) to produce the final
RyR1-YFP product. The completed RyR1-YFP and all intermediate
constructs were verified by sequencing at the DNA Sequencing and
Analysis Core of the University of Colorado-Anschutz Medical Campus
Cancer Center.
Analysis
Figures were made using the software program SigmaPlot (versions 7.0 and
11.0, Systat Software, San Jose, CA). All data are presented as mean5 SE.
Statistical comparisons were by unpaired, two-tailed t-test or one-way
analysis of variance (ANOVA) followed by a Dunnett’s post hoc test (as
appropriate), with p < 0.05 considered significant.
RESULTS
L-type current amplitude is greatly reduced in
RyR1-E4242G myotubes
Fig. 1 A shows representative families of L-type currents
recorded from normal and RyR1-E4242G myotubes. Typi-
cally, the density of L-type current recorded at the peak of
the I/V relationship (þ30 mV) from myotubes carrying the
RyR1-E4242G mutation was reduced by ~80% in compar-
ison to that of myotubes cultured from phenotypically
normal littermates (10.6 5 0.9 pA/pF; n ¼ 21 vs.
2.1 5 0.1; n ¼ 53, respectively; p < 1010, unpaired
t-test; Fig. 1 B). Although there was a larger range in the
individual current densities of normal (i.e., wild-type and
heterozygous) myotubes relative to current densities of
RyR1-E4242G myotubes, there was no overlap between
the groups (R.A.B. and K.G.B., unpublished observation).
A small depolarizing shift was observed in the activation
phase of the curve (V1/2 ¼ 20.0 5 1.3 mV and 24.1 5
1.0 mV, for normal and RyR1-E4242G currents, respec-
tively; p < 0.05, unpaired t-test; Table 1) and the reversal
potential for RyR1-E4242G L-type current was routinely
shifted by ~15 mV to more hyperpolarized potentials
(Fig. 1, B and C). Such a shift in reversal potential is char-
acteristic of low-amplitude L-type currents recorded
from myotubes under similar experimental conditions
(5,8,10,28) and likely arises from small outward leak cur-
rents. This being the case, a more accurate means of deter-
mining Gmax was required, because an inaccurate reversal
potential would distort the calculation of Gmax via Eq. 1.
Thus, tail current (Itail) analysis was employed to quantify
the effects of the RyR1-E4242G mutation on L-type chan-
nel gating. Tail current amplitude upon repolarization
to 50 mV is plotted as a function of the test potential be-
fore repolarization in Fig. 1 C; the tail currents for RyR1-
E4242G myotubes were substantially smaller (~80%) than
those of normal myotubes. A good fit with a single Boltz-
mann expression was not possible for the Itail/V relationship
of either group because of the entry of CaV1.1 into mode 2
gating at stronger depolarizations (32–34). However, no
obvious shift in the voltage-dependence of activation was
apparent when the Itail/V relationships were scaled to
peak Itail (Fig. S1 in the Supporting Material). Although
the augmentation of L-type current amplitude by the
1,4-dihydropyridine agonist 5Bay K 8644 (5 mM) in
FIGURE 1 L-type currents are substantially reduced in RyR1-E4242G
myotubes. (A) Representative families of L-type Ca2þ currents elicited
by 200 ms depolarizations to the indicated test potentials are shown for a
normal myotube (top) and an RyR1-E4242G myotube (middle). (B) Com-
parison of normal (C; n ¼ 21) and RyR1-E4242G (B; n ¼ 53) average
peak I/V relationships. Currents were evoked at 0.1 Hz by test potentials
ranging from 20 mV through þ80 mV in 10 mV increments (illustrated
at the bottom of A). Current amplitudes were normalized by linear cell
capacitance (pA/pF). The smooth I/V curves are plotted according to
Eq. 1. The best fit parameters for each plot are presented in Table 1.
Throughout, error bars represent mean 5 SE. (C) Comparison of normal
(C; n ¼ 11) and RyR1-E4242G (B; n ¼ 22) Itail/V relationships. Itail
was measured 1 ms after the onset of the repolarization from the indicated
test pulse to 50 mV (31). The analysis tail current amplitude excluded
cells with very small currents and cells in which tail current decay was
obviously not monoexponential.
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RyR1-E4242G myotubes was not as substantial as the
enhancement of the current in normal myotubes, RyR1-
E4242G L-type currents still displayed slowed deactivation
kinetics and hyperpolarizing shift in I/V relationship
(R.A.B. and K.G.B., unpublished observation).
The RyR1-E4242G mutation results in reduced
CaV1.1 expression and relative Po
Intramembrane gating charge movements were measured to
determine whether the decrease in L-type current density in
RyR1-E4242G myotubes was simply a consequence of
reduced CaV1.1 surface expression. The representative fam-
ilies of charge movements shown in Fig. 2, A and B, demon-
strate that the RyR1-E4242G mutation does indeed decrease
the number of CaV1.1 channels within the plasma mem-
brane. On average, charge movement observed in normal
myotubes (Qmax ¼ 5.9 5 0.7 nC/mF; n ¼ 6) was nearly
twice as large as that observed in RyR1-E4242G myotubes
(Qmax¼ 3.15 0.5 nC/mF; n¼ 17; p< 0.01; unpaired t-test;
Fig. 2 C; Table 1). The reduction in Qmax for RyR1-E4242G
myotubes indicates that decreased CaV1.1 expression was a
consequence of the RyR1-E4242G mutation, presumably as
a result of the loss of EC coupling (27), and is consistent
with earlier work showing that Ca2þ flux via RyR1 regulates
CaV1.1 expression levels (28).
Because RyR1-E4242G caused a reduced membrane
density of CaV1.1, we divided Itail (e.g., Fig. 3, A and B)
at each test potential by the average value of Qmax to yield
the relative channel open probability (Po) as a function of
test potential (Fig. 3 C). On the basis of these calculations,
relative Po in RyR1-E4242G myotubes was found to be
reduced ~55% in comparison to that of normal myotubes
(1.7 vs. 4.0 pA/fC, respectively, for repolarization
from þ30 to 50 mV). However, it is necessary to note
that the measured Qmax did contain endogenous immobili-
zation-resistant charge movement not attributable to
CaV1.1 (Qdys; (35)). Accordingly, the Itail/Qmax values
should be corrected by Qmax/(QmaxQdys). If one assumes
a Qdys value of 1.0 nC/mF (36–38), a substantial, although
reduced, difference in relative Po remains between normal
and RyR1-E4242G myotubes (4.8 vs. 2.6 pA/fC, respec-
tively, for repolarization from þ30 to 50 mV). Taken
together, the combined ~50% reduction in expression
and the ~55% reduction in Po account for the observed
~80% L-type current reduction in RyR1-E4242G
myotubes.
Importantly, Itail/Qmax for RyR1-E4242G myotubes was
larger than that of dyspedic myotubes (1.0 5 0.2 pA/fC
for repolarization from þ30 mV to 50 mV; Fig. 3 C).
Unlike the Itail/Qmax/V relationship for normal and RyR1-
E4242G myotubes, the Itail/Qmax/V curve for dyspedic
myotubes was fit well by a sigmoidal function, perhaps
because there was a reduced entry into mode 2 gating.
This result is consistent with the possibility that RyR1
plays a role in supporting the transition of CaV1.1 channels
from mode 1 to mode 2 gating (39). In summary, the data
presented in Figs. 2 and 3 indicate that RyR1s carrying the
E4242G mutation were less effective in causing the retro-
grade increase in relative Po compared to wild-type
RyR1, and that the loss of EC coupling produced by the
RyR1-E4242G mutation resulted in a reduced membrane
expression of CaV1.1.
The retrograde effect of RyR1 on activation
kinetics of the L-type current is little affected by
the RyR1-E4242G mutation
The activation phase of L-type current in skeletal muscle
can be best fit by the sum of two exponentials with time
constants, tfast and tslow, and amplitudes Afast and Aslow
(Eq. 2; and see Avila and Dirksen (8)). In agreement
with previous studies (8–10), both components of L-type
current activation were visibly slower in normal
(Fig. 4 A) than in dyspedic myotubes (Fig. 4 B). Surpris-
ingly, L-type currents recorded from RyR1-E4242G myo-
tubes (Fig. 4 B) retained the distinct slow activation
characteristic of normal skeletal L-type currents
(Fig. 4 A) and did not resemble the more rapid activation
kinetics of dyspedic myotubes (Fig. 4 C). Quantitative
analysis indicated that tslow and tfast for normal myotubes
(92.3 5 6.7 and 11.55 1.9 ms, respectively; n ¼ 14) and
RyR1- E4242G myotubes (99.0 5 11.2 and 13.8 5
1.5 ms, respectively; n ¼ 15) were not significantly
different (p > 0.05, one-way ANOVA followed by a
Dunnett’s post hoc test; Table 2), whereas those for
TABLE 1 Conductance and Intramembrane Charge Movement Fit Parameters
Cell Type
G/V Q/V
Gmax (nS/nF) V1/2 (mV) kG (mV) Vrev (mV) Qmax (nC/mF) VQ (mV) kQ (mV)
Normal 2515 2*** (21) 20.05 1.3** 5.4 5 0.2*** 81.45 1.6*** 5.9 5 0.7** (6) 3.2 5 3.9 8.15 1.0
RyR1-E4242G 845 6 (53) 24.15 1.0 7.9 5 0.4 67.05 2.0 3.1 5 0.5 (17) 1.7 5 6.0 8.25 1.7
RyR1-E4242Gþ RyR1-YFP 1195 11 (13) 16.55 2.3** 5.8 5 0.4* 77.45 2.6* ND
Dyspedic 44 5 6** (15) 17.75 1.9 8.7 5 0.8 68.55 4.2 3.7 5 0.4 (10) 2.7  1.5 11.85 1.0
I/VandQ/V curves are plotted according to Eqs. 1 and 3, respectively (see Materials and Methods). For all the data given, the calculated average voltage error
was <5 mV. Data are given as mean 5 SE, with the numbers in parentheses indicating the number of myotubes tested. Asterisks indicate significant
differences compared to L-type currents or charge movements recorded from RyR1-E4242G myotubes (*p < 0.05; **p < 0.01; ***p < 0.001; one-way
ANOVA followed by a Dunnett’s post hoc test). ND, not determined.
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dyspedic myotubes were much faster (39.2 5 10.0 and
3.3 5 2.8 ms, respectively; n ¼ 8; p < 0.001 and p <
0.005, respectively; Fig. 4 D; Table 2). The absolute values
of Aslow and Afast observed in normal myotubes (9.5 5
0.2 pA/pF and 1.5  0.2 pA/pF) were both considerably
larger than those of RyR1-E4242G myotubes (2.1 5
0.3 pA/pF and 0.6 5 0.1 pA/pF; both p < 0.001) and
those of dyspedic myotubes (0.6 5 0.1 pA/pF
and 0.35 0.1 pA/pF; both p < 0.001; Fig. 4 E; Table 2).
Although the relative contributions of Aslow and Afast to the
total current amplitude in normal (875 1% and 135 1%)
myotubes was somewhat different than the fractional con-
tributions in RyR1-E4242G (75 5 4% and 25 5 4%) and
dyspedic (745 7% and 265 7%) myotubes, these differ-
ences were not significant (Table 2). The kinetic differ-
ences between dyspedic and RyR1-E4242G myotubes
(i.e., tfast and tslow, absolute amplitudes of the respective
components) presented in Fig. 4 indicate that resting inter-
actions with the foot region of RyR1 are sufficient to slow
channel activation (40).
FIGURE 3 Relative Po as a function of test potential. Representative
families of tail currents elicited by repolarization to 50 mV after
200 ms test depolarizations (to 20 mV through þ80 mV in 10 mV incre-
ments) are shown for a normal myotube (A) and a RyR1-E4242G
myotube (B). Voltage protocol illustrated in Fig. 1 A, bottom. (C) Compar-
ison of relative Po (Itail/Qmax) for normal (C; n ¼ 11), RyR1-E4242G
(B; n ¼ 22), and dyspedic (A; n ¼ 9) Po. The relative Po values for
dyspedic myotubes have been fit according to Eq. 4 with the following
parameters: Itail/Qmax ¼ 1.15 0.3 pA/fC, Vtail ¼ 2.95 5.6 mV, and ktail ¼
10.45 2.3 mV. To obtain the measure of relative CaV1.1 Po, conductance
values (Itail) have been divided by the respective average Qmax values for
normal, RyR1-E4242G, and dyspedic myotubes (5.9, 3.1, and 3.7 nC/mF,
respectively; see Table 1).
FIGURE 2 CaV1.1 expression is reduced in RyR1-E4242G myotubes.
Charge movements elicited by 20 ms depolarizations from 50
to 30, 10, þ10, and þ30 mV are shown for a normal myotube (A)
and an RyR1-E4242G myotube (B). (C) Comparison of normal
(C; n ¼ 6) and RyR1-E4242G (B; n ¼ 17) Q/V relationships generated
by 20 ms depolarizations from 50 mV to test potentials ranging
from 40 mV through þ80 mV in 10 mV increments. Only on-charges
were analyzed because of the known ability of Cd2þ flux to contaminate
the off-component. The smooth Q/V curves are plotted according to
Eq. 3. The best fit parameters for each plot are presented in Table 1.
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L-type current density in RyR1-E4242G myotubes
is increased by exogenous expression of a wild-
type RyR1-YFP fusion construct
We next sought to determine whether exogenous expression
of wild-type RyR1 could completely rescue retrograde
coupling. Fig. 5 A shows a family of L-type currents re-
corded from an RyR1-E4242G myotube expressing a
wild-type RyR1-yellow fluorescent protein fusion construct
(RyR1-YFP). These currents were substantially larger than
any L-type current we measured in naive RyR1-E4242G
myotubes (compare to Fig. 1 B). RyR1-E4242G myotubes
expressing RyR1-YFP displayed a mean peak current
density (4.8 5 0.5 pA/pF; n ¼ 13; at þ30 mV) that was
significantly larger than that observed in naive RyR1-
E4242G myotubes (p < 0.001; unpaired t-test; Fig. 5 B)
or in naive dyspedic myotubes (1.2 5 0.1 pA/pF;
n ¼ 15; p < 0.001; unpaired t-test;). Although increased,
the current density in RyR1-E4242G myotubes expressing
RyR1-YFP was still considerably lower than in the normal
myotubes.
DISCUSSION
In this study, we found that the RyR1-E4242G mutation has
a profound effect on retrograde coupling between RyR1 and
CaV1.1 in skeletal muscle. L-type currents recorded from
homozygous RyR1-E4242G myotubes were reduced
~80% in comparison to those of phenotypically normal lit-
termates (Fig. 1). The reduction in peak current amplitude
was found to be the result of both a decrease in CaV1.1
plasma membrane expression and relative CaV1.1 Po
(Figs. 2 and 3, respectively). The disruption of retrograde
coupling in RyR1-E4242G myotubes resembled the loss
of retrograde coupling in dyspedic (RyR1 null) myotubes
FIGURE 4 Comparison of activation kinetics of L-type current in normal, RyR1-E4242G and dyspedic myotubes. Representative macroscopic Ca2þ
currents are shown for a normal myotube (A), a dyspedic myotube (B), and an RyR1-E4242G myotube (C). All currents analyzed were elicited by a
200 ms depolarization from 50 mV to þ30 mV (illustrated in C). Activation was fitted with a double-exponential function (Eq. 2) yielding time constants
tfast and tslow (D) with absolute (E) or fractional (F) amplitudes Afast and Aslow (8). The best fit parameters for each group are presented in Table 2. Asterisks
indicate significant differences (*p< 0.005; **p< 0.001) compared to RyR1-E4242G myotubes by one-way ANOVA followed by a Dunnett’s post hoc test.
The analysis of activation kinetics excluded cells with very small currents and cells in which tail current decay was obviously not monoexponential.
TABLE 2 Activation Fit Parameters
Aslow Afast
tslow (ms) Aslow (pA/pF) Fraction (%) tfast (ms) Afast (pA/pF) Fraction (%)
Normal 92.35 6.7 (14) 9.55 0.2** 875 1 11.55 1.9 1.55 0.2** 135 1
RyR1-E4242G 99.05 11.2 (15) 2.15 0.3 755 4 13.85 1.5 0.65 0.1 255 4
dyspedic 39.25 10.0** (8) 0.65 0.1 745 7 3.35 2.8* 0.35 0.1 265 7
All currents analyzed were elicited by a 200 ms depolarization from 50 mV to þ30 mVafter a prepulse protocol (see Materials and Methods). Activation
was fitted with a double-exponential function yielding time constants tfast and tslow with absolute or fractional amplitudes Afast and Aslow (Eq. 2; see Avila and
Dirksen (8)). Data are given as mean 5 SE, with the numbers in parentheses indicating the number of myotubes tested. Asterisks indicate significant
differences relative to RyR1-E4242G myotubes (*p < 0.005; **p < 0.001; as determined by one-way ANOVA followed by a Dunnett’s post hoc test).
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with one key exception—the activation kinetics of RyR1-
E4242G L-type current mirrored the slow activation kinetics
of normal L-type currents, rather than the rapidly activating
L-type currents of dyspedicmyotubes (Fig. 4). The retention
of wild-type current activation kinetics indicated that the
mutated RyR1 was capable of partial retrograde communi-
cation with CaV1.1. Exogenous expression of a wild-type
RyR1 construct restored L-type current density to ~45%
of normal myotubes (Fig. 5).
The first conclusion that can be made based on these ob-
servations is that the side chain of RyR1 residue E4242 is
critical for complete retrograde coupling between these
ion channels. The importance of this residue for RyR1 func-
tion is underscored by its conservation among mice, rats,
rabbits, and humans. It is unlikely, however, that this residue
represents a locus of physical interaction between the RyR1
and CaV1.1 (or an intermediary protein) as cryo-EM images
of RyR1 indicate that E4242 resides near the interface
between the myoplasmic foot domain and the sarcoplasmic
reticulum membrane-bound pore region of RyR1 (41–43).
These images of RyR1 suggest that a residue in this position
would be buried beneath the bulk of the foot region, ~12 nm
away from the voltage-sensing domains of CaV1.1. For
these reasons, we think it is more likely that the E4242G
mutation alters conformations of RyR1 that support bidirec-
tional communication with CaV1.1. The second conclusion
is that two or more interactions between RyR1 and CaV1.1
are involved in retrograde signaling, and these two interac-
tions are at least partially independent of one another.
Our results enable us to refine the model of bidirectional
coupling between RyR1 and CaV1.1 that was first proposed
by Nakai et al. (5) and expanded by Avila and Dirksen (8).
This model (Fig. 6) illustrates three signaling interactions
between CaV1.1 and RyR1: an orthograde EC coupling
signal and two separate retrograde signals. The orthograde
EC coupling signal is severely impaired by the RyR1-
E4242G mutation (27), as is the retrograde enhancement
FIGURE 5 Retrograde coupling in RyR1-E4242G myotubes is partially
restored by exogenous expression of a wild-type RyR1-YFP fusion
construct. (A) Representative family of L-type currents elicited by the
voltage protocol described in Fig. 1 A (bottom) are shown for an RyR1-
E4242G myotube expressing RyR1-YFP. (B) I/V relationships for RyR1-
E4242G myotubes expressing RyR1-YFP (C; n ¼ 13). I/V curves for
normal myotubes (C) and naive RyR1-E4242G myotubes (B) are replot-
ted from Fig. 1 B for comparison. The best fit parameters for each plot are
presented in Table 1.
FIGURE 6 Schematic diagram of bidirectional coupling between RyR1
and CaV1.1 and the effects of the RyR1-E4242G mutation on this coupling.
The red arrow represents the orthograde signal between RyR1 and CaV1.1.
The smaller green and yellow arrows represent the two components of
retrograde coupling (slowed activation kinetics and enhanced channel Po,
respectively). This model has been modified from a previous model (5) in
which these two separable components of retrograde signaling were consid-
ered to be inherently united and were represented by a single arrow. For
simplicity, a direct coupling between CaV1.1 and RyR1 is shown even
though such a direct coupling mechanism has not been confirmed (13).
Structural data seem to indicate that RyR1 residue E4242 is not involved
in direct interactions with the CaV1.1 channel complex or any other inter-
mediates that link the two channels (41–43). The model presented here is
consistent with the view that multiple loci of interaction between RyR1
and CaV1.1 support efficient EC coupling in skeletal muscle (for a review,
please see Beam and Bannister (44)). To see this figure in color, go online.
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of CaV1.1 Po (Fig. 3 C). However, the slowing of CaV1.1
activation kinetics is unaffected by the RyR1-E4242G muta-
tion. The two, retrograde modulatory effects of wild-type
RyR1 on the L-type current can be thought of as similar
to those of other auxiliary subunits of voltage-gated Ca2þ
channels (45). For example, CaVb subunits affect both Po
and kinetics of high-voltage-activated Ca2þ channels (for
a review, please see Buraei and Yang (46)). Suggestive evi-
dence in support of the idea that RyR1 behaves like a cyto-
plasmic subunit is provided by a previous study, which
demonstrated by means of fluorescence resonance energy
transfer that RyR1 causes rearrangement of the cytoplasmic
domains of CaV1.1 (47). Our present results indicate that
these components of retrograde coupling are separable
and therefore dependent on distinct structural elements
within RyR1.
Previous work has shown that in addition to causing
increased relative Po and slowed activation of the L-type
current, RyR1 also increases membrane expression of
CaV1.1, as indicated by Qmax (28). This latter effect depends
upon EC coupling Ca2þ release, which does not occur for
RyR1-E4242G. However, the relative Po should be unaf-
fected by any changes in CaV1.1 membrane expression
because our estimate of relative Po was obtained by calcu-
lating the ratio between Itail and Qmax. In regard to the
slowed L-type current activation caused by RyR1-
E4242G, it is interesting to note that previous work with
normal myotubes showed that activation was slower in cells
with lower CaV1.1 expression (48). However, we do not
think that this effect can account for the effect of RyR1-
E4242G on activation because Qmax was not significantly
different between dyspedic myotubes and RyR1-E4242G
myotubes (Table 1).
As mentioned above, the model shown in Fig. 6 indicates
that EC coupling is severely impaired by RyR1-E4242G,
which is based on our observations that were included in
Fig. 2 of Hanson and Niswander (27). In that work, it was
also shown that electromyographic (EMG) activity was
absent in directly stimulated diaphragms of E18.5 mice
homozygous for RyR1-E4242G, but restored by raising
extracellular Kþ from 3 to 6 mM. This effect cannot be
attributed to enhanced EC coupling because the EMG is
an event occurring upstream from activation of RyR1
(wild-type or mutant) by CaV1.1. It was also reported
that contractility (Fig. 3H of Hanson and Niswander (27))
was increased from zero in E18.5 diaphragms of RyR1-
E4242G homozygotes to one in such diaphragms exposed
to elevated Kþ, the KATP channel blocker glibencamide (2
mM) or Bay K 8644 (100 nM), where a contractility of
one was defined as either the presence of an EMG response
or a visual observation of movement. From these results,
it cannot be determined whether the movements were
weak or strong and whether they resulted from skeletal-
type EC coupling or another mechanism (e.g., Ca2þ flux
via CaV1.1).
L-type Ca2þ channels appear to have two open gating
modes, one of which (mode 1) is characterized by brief
openings and the other (mode 2) by longer-lasting openings
(32); transitions from mode 1 to mode 2 are promoted by
stronger and longer-lasting depolarizations (33). The pro-
gression of channels from mode 1 to mode 2 is reflected
macroscopically upon repolarization by tail currents that
are larger and more slowly decaying, and can account for
the observation that tail currents of wild-type and RyR1-
E4242G myotubes display an initial steep increase for
modest depolarizations followed by a shallower, but
ongoing, growth in amplitude for stronger depolarizations
(Fig. 3). RyR1 appeared to affect both components for
CaV1.1. Specifically, RyR1 appeared to increase the likeli-
hood of mode 1 openings inasmuch as it increased the
amplitudes of tail currents for modest prior depolarizations
(%20 mV) compared to those in dyspedic myotubes
(Fig. 3). RyR1 also appeared to promote the entry of
CaV1.1 into mode 2 openings. Thus, the tail currents of dys-
pedic myotubes obeyed a saturating Boltzmann dependence
on prior test potential (Fig. 3), as if entry into mode 2 does
not occur without RyR1 present. Consistent with the idea
that the presence of RyR1 promotes entry into mode 2,
and that entry into mode 2 does not occur without RyR1,
Fleig et al. (39) found that, compared to 50 ms depolariza-
tions to þ80 mV, 600 ms depolarizations evoked larger,
more slowly decaying tail currents in normal myotubes,
whereas such tail current enhancement was absent in dyspe-
dic myotubes.
We postulate that the partial restoration of L-type current
amplitude in RyR1-E4242G myotubes by reintroduction of
wild-type RyR1 (Fig. 4) was most likely a consequence of
increasing the number of junctional RyR1s that are fully
functional with regard to bidirectional signaling. Addition-
ally, restoration of EC coupling likely increased expression
of CaV1.1 (28). Still, further work is required to determine
whether the trafficking and assembly of RyR1s is adversely
affected by the E4242G mutation, and to determine the rela-
tive expression of the wild-type and mutant alleles in mice
heterozygous for RyR1-E4242G. This information is
needed to fully understand how heteromers of wild-type
RyR1 and RyR1-E4242G affect both orthograde and retro-
grade coupling.
Although the physiological significance of Ca2þ flux via
CaV1.1 has been the subject of much debate since the 1960s,
recent work has revealed that L-type Ca2þ entry maintains
myoplasmic Ca2þ levels during repetitive activity (49–51),
augments muscle contraction (52), engages excitation-
transcription coupling (51), and promotes formation of
neuromuscular junctions during development (53–55).
Moreover, conformational coupling between RyR1 and
L-type Ca2þ channels has been shown to trigger transient
elevations in cytoplasmic Ca2þ in neurons (56–60). Taken
together, these findings highlight the importance of
exploring the nature of CaV1.1-RyR1 conformational
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coupling, as it is clear that this interaction forms the mech-
anistic basis for the generation of some localized Ca2þ sig-
nals in neurons, as well as those required for EC coupling in
skeletal muscle.
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